Automated multi-objective calibration of biological agent-based simulations by Read, Mark N et al.
This is an author produced version of Automated multi-objective calibration of biological 
agent-based simulations.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/104877/
Article:
Read, Mark N, Alden, Kieran, Rose, Louis M orcid.org/0000-0002-3419-2579 et al. (1 more
author) (2016) Automated multi-objective calibration of biological agent-based simulations. 
Interface. ISSN 1742-5662 
https://doi.org/10.1098/rsif.2016.0543
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
Automated Multi-Objective Calibration of Biological1
Agent-Based Simulations2
Mark N. Read1,2,∗, Kieran Alden3, Louis M. Rose4, Jon Timmis33
1School of Life and Environmental Sciences, The University of Sydney, Australia.4
2Charles Perkins Centre, The University of Sydney, Australia.5
3Department of Electronics, The University of York, UK.6
4Department of Computer Science, The University of York, UK.7
8
∗Corresponding author: mark.read@sydney.edu.au9
10
11
Keywords: Computational Biology — Agent-Based Simulation — Calibration — Multi-12
Objective Optimization — Experimental Autoimmune Encephalomyelitis13
Abstract14
Computational agent-based simulation is increasingly used to complement lab-15
oratory techniques in advancing our understanding of biological systems. Calibra-16
tion, the identification of parameter values that align simulation with biological17
behaviours, becomes challenging as increasingly complex biological domains are18
simulated. Complex domains cannot be characterised by single metrics alone, ren-19
dering simulation calibration a fundamentally multi-metric optimisation problem20
that typical calibration techniques cannot handle. Yet calibration is an essential21
activity in simulation-based science; the baseline calibration forms a control for22
subsequent experimentation, and hence is fundamental in the interpretation of re-23
sults. Here we develop and showcase a method, built around multi-objective opti-24
misation, for calibrating agent-based simulations against complex target behaviours25
requiring several metrics (termed objectives) to characterise. Multi-objective cal-26
ibration delivers those sets of parameter values representing optimal tradeoffs in27
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simulation performance against each metric, in the form of a Pareto front. We use28
MOC to calibrate a well-understood immunological simulation against both estab-29
lished a priori and previously unestablished target behaviours. Further, we show30
that simulation-borne conclusions are broadly, but not entirely, robust to adopting31
baseline parameter values from different extremes of the Pareto front, highlighting32
the importance of MOC’s identification of numerous calibration solutions. We de-33
vise a method for detecting overfitting in a multi-objective context, not previously34
possible, used to save computational effort by terminating MOC when no improved35
solutions will be found. MOC can significantly impact biological simulation, adding36
rigour to and speeding up an otherwise time-consuming calibration process, and37
highlighting inappropriate biological capture by simulations that cannot be well38
calibrated. As such, it produces more accurate simulations that generate more39
informative biological predictions.40
1 Introduction41
Computational modelling and simulation has emerged as a tool for investigating a wide42
range of biological systems, spanning immunology [1][2], drug and intervention design43
[3][4], developmental biology [5], and ecology [6]. Biological simulation is particularly in-44
sightful when used in complement with traditional methods, such as wet-lab in vivo and in45
vitro work; laboratory work generates experimental data and suggests hypotheses that can46
be evaluated by way of their integration with simulation, which in turn can suggest further47
experiments or highlight areas of lacking knowledge [7][8]. Well designed, biologically-48
accurate simulations provide detailed spatio-temporal insight, facilitating observations49
and assays not possible in the real system; simulation experiments are unhampered by50
the ethical, practical and financial considerations inherent in biological experimentation.51
Research programs integrating wet-lab and simulation methods can offer a greater return52
on animal experimentation by generating additional insight, and hence easing the burden53
on experimental animals, in line with the ‘3Rs’ principles (Replacement, Reduction and54
Refinement).55
The agent-based simulation (ABS) paradigm permits detailed and nuanced simulation56
of biological systems [9][3]. Simulation components are represented as explicit individ-57
ual entities, agents, with unique states that exist within a spatial environment. Rules58
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specifying agent dynamics and the consequences of interaction are provided, and simu-59
lation execution allows the system-level consequences of agent-level manipulations to be60
observed. ABS incorporates stochastic events, and therein reflects the heterogeneity of61
real world natural systems. There is scope for specifying very detailed interactions using62
ABS, at the expense of generating large numbers of parameters: 50+ is not uncommon.63
Drawing biologically meaningful conclusions from simulation requires that the map-64
ping of the simulation to the biology is known. This can prove problematic for two65
reasons. First, simulations are abstract representations of their corresponding real world66
systems. For example, there exist at least 19 varieties of T cell, a vital component of the67
immune system [10]. However, rather than fully capture all their nuanced differences, a68
simulation is more likely to represent an abstracted subset thereof. As such, experimen-69
tal measurements on a real world T cell cannot be assumed to translate directly to its70
simulation counterpart. Second, complex biological systems are the subject of simulation71
precisely because they are incompletely understood, meaning that the real world data sup-72
porting simulation design decisions and corresponding parameter values may not exist.73
Calibration is a critical activity in establishing the link between simulation and biology;74
parameter values that align simulation and real-world dynamics are identified. Further-75
more, an inability to provide a good alignment points to simulation design that does not76
appropriately capture the biology. Calibration is used to establish a baseline simulation77
dynamic used as a control in subsequent experimentation, and finding appropriate values78
is important. Different parameter values will yield different simulation dynamics, and as79
such influence the conclusions drawn from experiments.80
A number of approaches to calibration exist, including manual calibration [11], evo-81
lutionary algorithms [12][13], maximum likelihood estimation and various forms of re-82
gression [14]. These techniques identify parameter values by employing a single metric83
to align simulation dynamics with those of the real world system. However, complex84
biological system dynamics are not well characterised by single metrics alone. They con-85
stitute many different types of interacting component, and encompass both positive and86
negative feedbacks. They are highly redundant: a single component can perform many87
functions and any one function can be performed by several components [15][16]. As such,88
calibration of a complex system simulation is fundamentally a multi-metric optimisation89
problem; several metrics of a simulation’s alignment with the biology must be simulta-90
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neously considered when evaluating putative parameter values. Consider, for example,91
cellular motility, which underlies many biological processes arising from cellular interac-92
tion. Which targets a given cell interacts with depends on both its speed and directional93
persistence; accurately modelling this process requires that metrics of both be considered.94
In this paper, we position multi-objective optimisation-based calibration (MOC: multi-95
objective calibration) as an important enabling technology for simulation-based biological96
investigation. Given its abstractive nature, a simulation undergoing calibration will not97
perfectly replicate all aspects of the biology. As such, putative simulation parameter value98
sets will exhibit tradeoffs in their reproduction of aspects of the biology, excelling in some99
at the expense of others. In this context, a metric quantifying a simulation’s capture100
of a specific aspect of the biology is termed an objective. Through the use of Pareto101
fronts (defined in Section 3), MOC explicitly tracks the collection of simulation parameter102
sets exhibiting optimal tradeoffs between objectives. It is unknown if adopting baseline103
parameter values from different regions of the Pareto front will deliver fundamentally104
different conclusions from simulation-based experiments. The answer to this question is105
likely problem-specific, and the use of MOC allows this issue to be addressed by exposing106
a full range of Pareto-equivalent solutions.107
Here we investigate multi-objective optimisation, specifically the NSGA-II algorithm [17],108
in calibrating an established immunological simulation: ARTIMMUS [18]. ARTIMMUS109
simulates Experimental Autoimmune Encephalomyelitis (EAE), a mouse model of multi-110
ple sclerosis [19][20]. It is a complex simulation, encompassing seven distinct cell popula-111
tions that interact across five organs, and constituting 72 parameters. Its successful prior112
manual calibration renders it an effective test case for evaluating MOC’s applicability to113
simulation calibration. We demonstrate the successful calibration of ARTIMMUS using114
five objectives (Section 4): a range of solutions to the calibration problem, offering optimal115
tradeoffs against calibration objectives, are generated. Furthermore, we demonstrate that116
conclusions drawn from a simulation-based experiment can vary depending on exactly117
which calibration solution is adopted (Section 5). Hence, different calibration solution118
parameter values can vary downstream conclusions, highlighting MOC’s value in making119
these multiple solutions explicit. We show that MOC is equally applicable in generating120
simulation initial condition values: cellular population sizes as simulation launch. We121
proceed to demonstrate that MOC can identify parameter and initial condition values122
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that deliver previously unknown simulation dynamics, highlighting its potential beyond123
this well understood test case (Section 6). Lastly, we consider strategies for formulat-124
ing stopping criteria for MOC, thereby preventing over-fitting and wasted computational125
expense when apparent improvements in simulation calibration are likely due to stochas-126
tic sampling rather than genuinely superior parameter values (Section 7). We begin by127
introducing ARTIMMUS (Section 2), and the MOC methodology (Section 3).128
2 A testbed for calibrating biological simulations129
ARTIMMUS is an agent-based simulation of an EAE protocol wherein mice induced into130
autoimmunity undergo a natural recovery from disease, and are thereafter resistant to131
disease re-induction [18][21][22]. ARTIMMUS was created, in part, to further probe the132
cellular interactions mediating this recovery [23][24]. It has been used to explore the133
mechanisms through which splenectomy, the removal of the spleen, a primary immune134
organ, exacerbates disease severity, and predict the outcome of T cell interaction-blocking135
drugs [18]. It was conceived through a collaboration of immunologists and computer136
scientists, and developed through a principled approach focusing on documenting how137
biological concepts are translated into computer code: the CoSMoS process [32]. It is138
written in the Java programming language.139
ARTIMMUS has previously undergone a by-hand, manual calibration [11], and was140
shown to reflect the dynamics of the real world disease [18]. The process demanded close141
collaboration between the simulation developer and an immunologist who informed the142
work, helping bridge biological data and concepts to simulation constructs and output.143
This manual calibration took two weeks, and entailed an iterative process through which144
simulation code and parameter value changes that might explain perceived discrepancies145
between simulation and biological system dynamics were identified and explored in turn.146
Those best aligning simulation with biological dynamics were adopted before repeating147
the process. This calibration approach is akin to a non-population, manual, greedy local148
search wherein the best immediate improvement is always adopted.149
Despite delivering a well-calibrated result for ARTIMMUS, this calibration search150
strategy presents several potential pitfalls. It is entirely plausible that the manual search151
does not find the global optimum parameter set that best aligns simulation dynamics with152
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those of the biological system. As a greedy search strategy, its result is highly dependent153
on the search’s starting position, and complex landscapes where one parameter’s influence154
on simulation dynamics critically depends on the values held by others are particularly155
challenging. The existence of multiple solutions to the calibration problem can go entirely156
undetected. Lastly, manual calibration is time consuming, and agent-based simulation’s157
stochastic nature furthers compound these challenges. It is these issues that collectively158
motivated the present automated MOC approach.159
Here we provide a brief summary of EAE and ARTIMMUS to aid understanding of160
the sections that follow; a comprehensive description may be found in the supplementary161
materials of [18]. Figure 1A provides an abstract overview of the major cell types in-162
volved in EAE, and their relationships to one another. EAE is induced through injection163
of neuronal fragments which are internalized by dendritic cells (DCs) which then direct164
the growth of a T cell population (CD4Th1, abbreviated to Th1) targeting these frag-165
ments. These Th1 cells enter the central nervous system (CNS), where they stimulate166
CNS-resident macrophages into secreting TNF-α, which in turn damages neurons. The167
resultant neuronal fragments are internalized by further populations of DCs, which direct168
further Th1 activities, perpetuating the autoimmune cycle. Recovery from autoimmunity169
is through the actions of two populations of regulatory T cell, CD4Treg and CD8Treg170
cells, so named as they regulate the activities of other T cells. The natural life-cycle of a171
Th1 cell results in its eventual death and internalization by DCs, which derive fragments172
therefrom and direct the growth of CD4Treg and CD8Treg cells targeting the Th1 cell173
population. CD4Tregs play an essential role in facilitating the development of CD8Treg174
cells. CD8Treg cells can directly kill Th1 cells, interrupting their natural life-cycle and175
preventing the perpetuation of autoimmunity. Th2 cells directly compete with Th1 cells,176
as both arise from a common progenitor and they each perform downstream activities177
that promote their own development. The reduced severity of the autoimmune environ-178
ment arising from the action of CD8Treg cells favours the growth of Th2 cells over Th1179
cells, which do not directly harm neurons and hence do not contribute to this autoimmune180
process. Figure 1B shows a time-series graph of T cell population sizes in ARTIMMUS.181
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3 Multi-objective calibration (MOC) methodology182
We present here an overview of the multi-objective calibration (MOC) concept, detailing183
how we employ mutli-objective optimisation technology to calibrate simulation parameters184
and initial conditions. A graphical overview is supplied in Figure 2.185
Firstly, we define the desired (target) ARTIMMUS dynamics, Figure 2A. In this186
manuscript targets are expressed as peak cell population sizes, the times at which those187
peaks occur, or the cell population sizes at a given time. Target dynamics might repre-188
sent known biological results to be reproduced, or hypothetical outcomes of interest. In189
this study we adopt the dynamics of a previous manual calibration of ARTIMMUS, so190
as to evaluate MOC on a well-understood problem; thereafter we employ MOC to obtain191
hypothetical dynamics not known possible a priori. We note that many other aspects192
of simulation performance can constitute target dynamics, depending on the context and193
simulation being calibrated. The expression of targets as distributions reflects the stochas-194
tic nature of biological systems and agent-based simulations, wherein repeat experiments195
can yield slightly different results.196
MOC seeks to identify parameter values that best align simulation with target dynam-197
ics. As such, we define metrics, termed objectives, that quantify the alignment between the198
two. As illustrated in Figure 2B (left), we employ the the non-parametric Kolmogorov-199
Smirnov statistic in our objectives, which quantifies the difference in target and simulation200
dynamics for a given set of simulation parameter values. Rather than contrasting the me-201
dians of two distributions, as many statistics do, the KS statistic quantifies the biggest202
distance between two distributions’ cumulative distribution functions. As such, its use203
here facilitates the calibration of a distribution’s shape, not simply its median or mean.204
We consider this a strength of our approach; as may be seen in the sections that follow,205
MOC is capable of reproducing distributions of behaviour, not simply averages. Each206
set of simulation parameter values is termed a ‘candidate solution’, and its corresponding207
simulation performance is evaluated against each objective individually. By evaluating208
many candidate solutions we identify regions of parameter space providing close align-209
ment with target dynamics (Figure 2B, right). Importantly, the regions that satisfy each210
objective differ. In practice, it is computationally intractable to fully explore parameter211
space as suggested by the heatmaps in this Figure, particularly when many parameters212
are investigated. Instead, a heuristic (guided) search strategy is employed that samples213
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parameter space, evaluates performance, and decides from where to extract the next can-214
didate solutions based on the results. In this study we employ NSGA-II as our guided215
search engine [17], but we believe other multi-objective optimisation technologies could216
be successfully substituted. NSGA-II maintains a population of candidate solutions, and217
employs (heavily abstracted) principles of genetic recombination, mutation and natural218
selection to generate and evaluate successive generations of superior candidate solutions.219
Hence, NSGA-II is an iterative algorithm. We refer the readers to [17] for more detail on220
NSGA-II. Here we have employed the ‘inspyred’ python module NSGA-II implementation.221
We identify those candidate solutions that constitute optimal tradeoffs in performance222
against each objective, referred to simply as solutions, Figure 2C. The set of solutions223
is termed the Pareto front. These solutions are Pareto-equivalent : no solution has been224
found that offers an improvement in one objective without a worsening in another. Pareto-225
equivalent solutions may reside in disparate regions of parameter space, and the ability to226
recognize this is a key strength of MOC. Though these regions of parameter space may be227
Pareto-equivalent for the given target simulation behaviour, they could yield very different228
behaviours when subjected to further downstream experimentation, and as such lead to229
different simulation-borne conclusions. In this study we investigate this phenomenon for230
a given experiment in ARTIMMUS.231
We note that it is possible to derive a great many targets and objectives for complex232
system simulations. Increasing the number of objectives increases the difficulty of the233
calibration problem, and the computational resource required to address it; in the field234
of optimisation this is known as the ‘curse of dimensionality’. Hence, employing fewer,235
uncorrelated objectives is considered good practice: it encourages the identification of236
good quality solutions whilst minimising the resources required to do so.237
3.1 Selecting candidates from the Pareto front238
Upon completion MOC delivers a Pareto front of Pareto-equivalent solutions, representing239
optimal tradeoffs between the calibration objectives. Deciding which solution adopt as the240
baseline simulation parameter values is an application-specific problem. For the present241
study we have developed a function, Λ(c), which assesses candidate solution c against242
the criteria below. We select the candidate with the lowest Λ value when presenting the243
results of calibration below. Λ is calculated as follows.244
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Let Ω represent the set of calibration objectives, and KSo(c), o ∈ Ω as the correspond-245
ing Kolmogorov-Smirnov score for candidate c on objective o. KS(c) represents the mean246
objective score for candidate c. The Λ score is calculated as:247
Λ(c) = α ·KS(c)2 +
∑
o∈Ω
(
KSo(c)−KS(c)
)2
(1)
Low Λ scores are achieved through low mean objective KS scores, and balanced KS248
scores across all objectives. α specifies the relative importance of these two components.249
When α = 1, both measures contribute equally to Λ. Lower mean KS scores are prioritised250
with α >1, and vice versa. We employ α = 1 throughout. We note that Λ is unit-less, and251
as such is not explicitly reported here; it is used only to extract one candidate solution252
from a Pareto front, presented as the chief result of calibration in the results that follow.253
4 Successful re-calibration of ARTIMMUS254
We demonstrate MOC by re-calibrating ARTIMMUS, taking as target dynamics those of255
the previous manually-calibrated simulation dynamics [18]. As these dynamics are known256
to be obtainable, and at least one set of parameter values that produce them are known,257
we are able to evaluate MOC’s performance.258
With 5 objectives MOC successfully reproduced the manually-calibrated ARTIMMUS259
dynamics, as demonstrated in Figure 3. The objectives used were:260
• the peak Th1 cell population size (Figure 3B)261
• the time at which the peak occurred (Figure 3C)262
• the Th2 population size at 30 days (Figure 3D)263
• the peak population sizes of both CD4Treg and CD8Treg cells (Figures 3E and F).264
The corresponding target distributions of values are also shown in Figure 3.265
Each candidate solution generated by NSGA-II was assessed through 200 replicate266
simulation executions. The target distributions against which candidates are contrasted267
are derived from 500 replicates generated with the previous manual-calibration parameter268
values. The manual-calibration’s replicates need be executed once only and stored, they269
do not change. In contrast, assessment of candidates is computationally costly because270
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so many are generated; a figure of 200 replicates per candidate was selected to strike a271
balance between experimental sensitivity and computational cost. A previous analysis of272
parametric perturbation in ARTIMMUS established that contrasting distributions com-273
prising 200 replicate executions was sufficient to detect ‘small’ changes in 2
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of simulation274
behaviour metrics, and ‘medium’ in the remainder [11]. Hence, we consider 200 replicates275
to offer sufficient sensitivity in differentiating candidate performances. These effect size276
categories arise from the analysis’s use of the Vargha-Delaney A test [25], which provides277
interpretation guidelines. For reference, the A test is a non-parametric effect magnitude278
test representing the probability that a randomly selected member of one distribution is279
larger than a randomly selected member of the other. An A test score of 0.5 indicates280
the two distributions are indistinguishable (using this test). Values of 1 and 0 indicate281
no overlap in the two distributions. A single calibration exercise required around 5 days282
on a dedicated computational cluster able to execute 120 simulations simultaneously;283
each single simulation replicate takes around 2-10 minutes to execute, depending on the284
parameter values used.285
We have successfully applied MOC to both ARTIMMUS parameter values and ini-286
tial conditions, but focus here on the former. Initial condition calibration results are287
reported in the supplementary materials. Calibration was performed over 8 ARTIMMUS288
parameters which all pertain to presentation of substances to T cells, particularly Th1289
and Th2 cells, and their resultant development. The biology captured in these parame-290
ters is outlined in supplementary Figure S1, and we note that a through understanding291
of this biology is not required to appreciate our results. These parameters were selected292
for the reasons that ascertaining their values experimentally would be challenging and293
they all relate to a critical aspect of the biology: the perpetuation of autoimmunity, and294
(for some) it’s amelioration (as Treg cell development is also directed by DCs). Hence,295
by successfully calibrating parameter values that are highly influential on simulation dy-296
namics we demonstrate MOC’s potential. Parameters were given a constrained range of297
values that the MOC process could assign, being zero to twice their manually-calibrated298
range, as shown in Table 1. In exploring the space of putative parameter values, NSGA-II299
maintained a population of 64 candidate solutions which were subject to genetic recombi-300
nation and mutation (see [17]) over 32 generations of natural selection, wherein only the301
best 64 solutions (i.e. those on or near the Pareto front) were retained in the successive302
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generation.303
This calibration exercise was repeated three times for both parameters and initial304
conditions. Figure 3 shows the solution with the lowest Λ score from one such parameter305
calibration. The remaining two are shown in supplementary Figures S2 and S3. The306
calibrated simulation dynamics closely resemble the target distributions in all cases. The307
three parameter calibration exercises generated, respectively, Pareto fronts constituting308
82, 87 and 112 Pareto-equivalent solutions. The ranges of parameter values represented309
across the Pareto fronts’ solutions in each independent calibration exercise are shown in310
Figure 4, as are the baseline manually-calibrated values. In all but one case the baseline311
parameter value sat within the range of non-outlier MOC-derived values, the exception312
being Th1 diff80 in exercise 3. Hence, we conclude that MOC is an effective means313
of calibration: it has repeatedly reproduced ARTIMMUS dynamics that were known314
possible, and has identified similar solutions, in the form of parameter values, that do so.315
Next we investigated how the space of ARTIMMUS parameter values relates to the316
space of successful target dynamic reproductions, i.e., tradeoffs in objective values. We317
find statistically significant (p<0.01) differences between calibration exercises’ distribu-318
tions of calibrated parameter values for 7 of 8 parameters, Figure 4. This corresponds319
to 19 of 24 (79%) of pairwise comparisons. Further, 75% (18/24) pairwise comparisons320
register a KS value ≥ 0.3. For context, a KS value of 1.0 indicates no overlap between 2321
distributions. In contrast, this degree of variation is not observed in Pareto fronts’ objec-322
tive values, depicted in Figure 5. Here we instead find statistically significant differences323
in only 27% (4/15) pair-wise calibration comparisons, and only 27% (4/15) of compar-324
isons register KS≥0.3. We find no evidence of objectives that are harder to calibrate325
than others; the smallest objective values are <0.05 in all cases, and the median objective326
values all lie under 0.17.327
Together, these data suggest a redundancy in the ability for parameter values to328
deliver particular objective scores. This corresponds to a landscape wherein parameter329
values mapped to objective values is relatively flat, as a wide range of ARTIMMUS330
parameter values deliver relatively similar objective scores. The results of using MOC331
to calibrate ARTIMMUS initial conditions are reported in supplementary Section S1, and332
supplementary Figures S4, S5 and S6. They are qualitatively identical to our findings in333
calibrating parameters, and support the conclusions drawn here.334
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An obvious question is, why does MOC not deliver any perfectly calibrated solutions,335
wherein all objective scores are 0.0? The best solutions, determined by their minimal Λ336
values, in each calibration exercise are shown in Table 2. Objective KS values ranged337
from 0.05 to 0.14 (and 0.03 to 0.12 for initial conditions). We attribute the inability to338
deliver a perfect calibration to the stochastic nature of ARTIMMUS, wherein 200 replicate339
executions for a given candidate yields sufficient variation so as to deliver objective KS340
scores of ≥0.05. There is a risk that improvements in objective KS values that are already341
so small cannot be confidently attributed to an actual improved simulation calibration, as342
opposed to stochastic variation between simulation replicates. Section 7, below, explores343
a method for terminating the MOC process on the premise that further effort will not344
deliver better quality solutions.345
These data collectively highlight the challenges in exactly calibrating (i.e. KS=0.0)346
simulations to several objectives simultaneously. As such, we consider in the next Sec-347
tion the implications on experimental results of adopting baseline simulation values from348
different extremes of the Pareto front.349
5 Scientific significance of imperfect calibration350
As demonstrated above, MOC delivers a host of solutions to a given calibration problem,351
each representing an optimal tradeoff in calibration criteria (see Figure 2). It falls on the352
simulation developer to decide which to adopt baseline parameter values in subsequent353
experimentation. There is a risk that whilst calibration solutions lying in different regions354
of parameter space give rise to Pareto-equivalent solutions, they do not behave in a355
consistent manner when further experiments are performed. In such a case, a simulation-356
based experiment would lead to different conclusions depending on which calibration357
result was adopted as the baseline. In this section we investigate the extent to which this358
phenomenon holds.359
The manually-calibrated ARTIMMUS simulation was previously used to elucidate the360
effect of removing a central immune organ, the spleen (a splenectomy), in EAE-induced361
animals [18]. Previous experiments had demonstrated that splenectomy in rats prior to362
the induction of EAE increased the mortality rate and hampered recovery [26]. Simulating363
splenectomy in ARTIMMUS revealed the spleen as a primary site for the generation of364
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autoimmunity-combating CD4Treg and CD8Treg cells. The reduced Treg populations365
resulting from the spleen’s removal prior to EAE-induction were unable to completely366
abrogate the autoimmunity-inducing Th1 populations, allowing for their re-expansion,367
and thus facilitating increased disease severity and relapses.368
Here we explore whether the results of splenectomy in ARTIMMUS differ when base-369
line parameter values are adopted from disparate extremes of the Pareto front. The370
experimental procedure is highlighted in Figure 6. First, Pareto front solutions represent-371
ing the extreme values, both low and high, of objective KS measures are identified. These372
solutions represent extremes in the range of simulation dynamics encapsulated within the373
Pareto front. For each solution 200 simulation replicates are performed for both control374
and splenectomy groups. Key performance indicators (KPI) are extracted from the resul-375
tant distributions of 200 simulation executions in each group. The performance indicators376
used are identical to those of the original ARTIMMUS splenectomy experiment [18]: the377
peak population sizes for each T cell population in the simulation, the times at which378
these peaks are reached, and the number of Th1 cells remaining at day 40 (giving a total379
of 9). For each KPI, the distributions of values obtained for control and splenectomy380
groups are contrasted using the Vargha-Delaney A test [25], as per the original experi-381
ment [18]. This procedure is repeated for each of the three calibration exercises reported382
in Section 4. The resultant A test scores are shown in Figure 6’s tables. Also shown, for383
context, are the A test scores of the original ARTIMMUS experiment [18].384
Broadly speaking, the splenectomy results generated by Pareto-equivalent solutions are385
consistent with one another, and with the original experiment. There exceptions, however,386
wherein differences in A test scores reported for solution and the original experiment387
differed substantially: g23c60 in exercise 1, and g6c35 and g30c58 in exercise 2. These388
differences occurred for ‘Th1 at 40d’, ‘Th2 peak’ and ‘Th2 Time’ KPIs. Of interest, three389
of these solutions were obtained from the region of the Pareto front where alignment with390
target Th2 peak population size was poorest. In the case of g23c60 and g6c35, exercises 1391
and 2 respectively, the parameter values where sufficient to return Th1 population size at392
40 days to control group levels, despite the splenectomy (A=0.58 and 0.56; 0.5 indicates393
no difference). This is significant, as the principle conclusion of the original experiment394
was that splenectomy reduces Treg population sizes to levels unable to suppress Th1 cell395
populations and abrogate autoimmunity. The time series T cell population dynamics of396
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both these solutions under control and splenectomy are shown in supplementary Figure S9.397
In both cases the peak Th1 population sizes are smaller than in the original experiment398
(see Figure 6)), and the Th2 population sizes are substantially larger. Based on this we399
hypothesize that despite reduced Treg population sizes resulting from splenectomy, the400
altered balance between Th1 and Th2 populations which compete with one another is401
sufficient to abrogate the Th1 population at day 30 in these solutions.402
Supporting the notion that solutions’ results are relatively consistent, the direction of403
change in solutions’ KPIs resulting from splenectomy differs from the original experiment404
in only a minority of cases. Further, this occurs only in KPIs for which the original405
experiment reports a comparatively small change between splenectomy and control, the406
largest being in exercise 2 when the original experiment reports a change of A=0.66, which407
was not interpreted as significant.408
We have conducted the same investigation on Pareto-equivalent solutions generated409
under the three independent initial condition calibration exercises (supplementary Section410
S1). Detailed analysis is reported in supplementary Section S2 and Figure S10; briefly,411
divergences between initial condition solution and original experiments were smaller than412
reported here for parameters. We take this to indicate that the initial parameters in-413
vestigated were less influential on simulation behaivour than the parameters investigated414
here.415
In summary, the conclusions that would be drawn from adopting baseline parameters416
values from disparate Pareto-equivalent solutions are mostly, but not completely, consis-417
tent with one another and with the original splenectomy experiment. There were two418
notable exceptions, and they underscore the importance of considering the range of sim-419
ulation performances that satisfy a calibration exercise. Making these explicit through420
Pareto fronts is a strength of the MOC approach. It remains important to, where possi-421
ble, further evaluate Pareto-equivalent solutions in the context of domain knowledge and422
expertise, which might have ruled out the two exceptions noted above, as the Th2 popula-423
tion size is abnormally large compared to the Th1 population. Where this is not possible,424
where no grounds to discard some Pareto-equivalent solutions exist, we advise that ex-425
periments are performed in replicate adopting a wide range of calibration solutions and426
that conclusions are drawn after taking stock of the full range of results generated. This427
is particularly important if quantitative, rather than qualitative, results are sought; our428
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present data show more divergence between calibration solutions and original experiment429
in the quantitative case.430
6 Multi-objective calibration delivers previously un-431
seen disease phenotypes432
In Section 4, above, MOC successfully reproduced simulation dynamics known to exist433
by virtue of a prior manual calibration. To further demonstrate MOC’s generality and434
utility, we now derive simulation dynamics not known to exist a priori.435
ARTIMMUS’s baseline behaviour constitutes a period of autoimmunity followed by436
recovery, reflecting typical biological disease [21][22]. However, disease susceptibility437
and severity vary considerably between mouse strains and between mice within a given438
strain [27][28]. Furthermore, depletion or incapacitation of CD4Treg and CD8Treg cells439
leads to exacerbated disease symptoms [29][30]. Here we investigate the capacity for440
ARTIMMUS to reproduce persisting disease symptoms of varying severity. To reflect441
potential genetic differences between mouse strains, we calibrate over initial conditions442
specifying cell population sizes, and a parameter controlling the efficiency of Th1 killing443
by CD8Treg cells; together comprising 9 variables. In this experiment we are implicitly444
investigating whether variation in these basal population sizes and the efficiency of the445
CD8Treg-Th1 killing pathways could explain the differences in autoimmune phenotypes446
observed between mouse strains and individuals therein.447
Three persisting disease severities are investigated, ranging from mild to severe. These448
are captured by defining the distribution of Th1 cells remaining at 60 days as a target for449
calibration, captured as a Guassian distribution. Mild, moderate and severe disease are450
represented with mean (µ) and standard deviation (σ) values of µ=50 & σ=10, µ=200 &451
σ=100, and µ=500 & σ=200 respectively. To ensure an aggressive onset of autoimmunity,452
consistent with animal models, a second calibration target distribution of µ=1000 &453
σ=200 Th1 cells at 15 days is employed.454
Each persisting autoimmunity severity is independently calibrated three times, rep-455
resentatives of which are shown in Figure 7 (the remainder are shown in supplementary456
Figures S11, S12 and S13). Automated calibration successfully delivers the required me-457
dian number of cells in most cases, with KS≤0.2 in 6 of the 9 calibrations. However, the458
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spread of the ‘Th1 cells at 60 days’ distribution for mild persisting disease is notably less459
well calibrated, with all three calibrations delivering KS>0.3.460
Together, these data support the general applicability of MOC to problems where a461
simulation’s ability to deliver a desired dynamic is not known a priori. These data also462
suggest that the heterogeneity in disease severities observed in experimental animals could463
be attributed to differences in basal population sizes and regulatory pathway efficiency.464
7 When to stop MOC465
A key consideration in any optimisation task is the stopping criteria. For MOC, under-466
pinned by the NSGA-II optimisation algorithm, this equates to determining when to stop467
calibration.468
Overfitting describes the case where the simulation being calibrated starts to capture469
the noise in the target distributions, rather than the trends those distributions represent.470
This is a particular issue when target distributions do not contain many samples, as471
might be the case if they represent biological experiments (Figure 8A). For example,472
studies involving experimental animals can require their sacrifice to collect data. As such,473
it is considered unethical (and is practically cumbersome) to collect hundreds of samples,474
and 5 to 10 are more typical. These smaller sample sizes are unlikely to perfectly capture475
the underlying distribution that would emerge if thousands of samples were available.476
Overfitting is said to have occurred when the calibrated simulation better reflects these477
5-10 samples than their underlying distribution, as illustrated in Figure 8B.478
A common strategy in single-objective (not MOC, which is multi-objective) problems479
for determining when to terminate an optimisation process is to segregate the available480
data into two parts, termed ‘training’ and ‘validation’ datasets. The training dataset481
is used as normal to search for improved solutions, akin to MOC’s target data. The482
validation dataset is used as an independent check for overfitting of solutions to the483
training data set. Such a case of overfitting is depicted in Figure 8C. Both the training484
and validation data roughly reflect the underlying distribution, from which they were485
sampled. The candidate solution more closely resembles the training dataset than either486
the underlying distribution or the validation dataset, hence, it is overfitted. As illustrated487
in Figure 8D, in the earlier stages of optimisation successive candidate solutions that488
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better capture the training dataset will also better capture the validation data. It is only489
when overfitting starts to occur that performance against the validation data worsens490
whilst performance against training data continues to improve. It is at this point that491
the optimisation process is best terminated.492
MOC is, however, a multi-objective optimisation problem, and it is unclear in the lit-493
erature how this overfitting detection strategy ought be applied. We propose here a novel494
strategy for detecting overfitting in mutli-objective problems based on co-membership of495
solutions to both training and validation dataset Pareto fronts (Pt and Pv), maintained496
throughout the calibration process (Figure 8E). The overfittedness at a given point in the497
optimisation process is reflected in the proportion of Pt members that are not members498
of Pv. The following algorithm performs the calculation:499
m← 0500
for all i ∈ Pt do501
if i ∈ Pv then502
m← m+ 1503
end if504
end for505
return 1− (m/size(Pt))506
A proportion of 0 indicates that all training dataset Pareto solutions are also members507
of the validation Pareto front. At the other extreme, a value of 1 indicates that the training508
dataset Pareto front has been completely over-fitted, as none of its members are Pareto509
optimal with respect to the validation dataset. A threshold level of over-fitting at which510
the optimisation process (i.e., MOC) is to be terminated can be selected by the simulation511
experimenter.512
We investigated different overfitting thresholds for MOC termination in the three513
ARTIMMUS parameter recalibration exercises reported in Section 4 above. An additional514
214 simulation replicates using manually-calibrated parameter values were acquired to use515
as a validation dataset, constituting a 70-30 (500-215) training-validation data split. The516
validation dataset Pareto front for each iteration of the MOC algorithm (generation) was517
determined, and the overfittedness calculated. Figure 9A shows how, as MOC progresses,518
the proportion of overfitted candidate solutions on the training (target) dataset increases519
for each of the three calibration exercises. Figure 9B shows the point at which MOC520
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calibration would have been terminated should a given overfittedness threshold have been521
selected. Had we employed a overfittedness termination threshold of 0.5, wherein half522
of the training dataset Pareto front is overfitted, calibration would have terminated at523
generation 14, 15 or 23 (for exercises 1, 2 and 3 respectively) instead of 32. Given that524
each of these calibration exercises required around 7 days to complete on a dedicated525
computing cluster, this speed-up is substantial. We note that these combined training526
and validation datasets constitute 714 data points, considerably exceeding what might527
be obtained from real biological experiments. We anticipate that with fewer data points528
overfitting will occur sooner in the MOC process.529
8 Discussion530
Simulation represents a powerful tool to advance the investigation of biological systems,531
particularly when used in tandem with traditional approaches. As more complex biolog-532
ical systems become the subject of simulation a challenge in their calibration emerges:533
complex biological systems cannot be characterised by single metrics alone. There exist534
technologies capable of identifying parameter values that align simulation dynamics with535
some desired target, but these operate on single metrics. Even in cases where param-536
eter values can be ascertained experimentally, seemingly avoiding the need for calibra-537
tion, the abstract nature of simulation can complicate their direct adoption. Here we538
have demonstrated how biological agent-based simulation parameter values can be de-539
rived using multi-objective optimisation, an approach we have termed Multi-Objective540
Calibration (MOC). Multi-objective optimisation algorithms find solutions to problems541
simultaneously described by more than one metric. In MOC the desired characteristics542
of the simulation, which can represent either established biological data to be reproduced543
or some desired hypothetical simulation outcome, are expressed as distributions. Impor-544
tantly, several such characteristics can be expressed, and MOC identifies those sets of545
parameter values that deliver optimal tradeoffs against each.546
We evaluated MOC on a well understood simulation, using it to reproduce a pre-547
vious manual calibration effort and therein delivering a solution that was known to be548
possible. The ARTIMMUS simulation was used, which simulates a mouse multiple scle-549
rosis disease model [18]. MOC delivered around 90 unique parameter value combinations,550
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each of which provided an optimal tradeoff in performance against the 5 target ARTIM-551
MUS characteristics specified. This range of possible calibration solutions was unknown552
a priori ; the previous manual calibration of ARTIMMUS having delivered only one such553
solution [11]. It would ordinarily fall on the simulation user to select one solution (set554
of parameter values) to adopt as a baseline for subsequent simulation experimentation.555
We investigated the significance of selecting solutions representing different extremes of556
tradeoffs in delivering target simulation characteristics. A previous experiment with AR-557
TIMMUS determined that removing the spleen, an important immune system organ,558
resulted in exacerbated autoimmune symptoms. The results of re-performing this exper-559
iment with different MOC solutions adopted as baseline parameter values were broadly,560
but not absolutely, similar. Hence, adopting different calibration solutions can lead to561
different experimental conclusions. It a strength of MOC that this range of solutions is562
made explicit. Where possible, we recommend that MOC solutions be evaluated against563
biological data to discard those that represent biologically unrealistic parameter values or564
behaviours. Where this is not possible, we advocate performing experiments in replicate565
using multiple MOC solutions such that the full range of possible results be established566
before conclusions are drawn.567
We demonstrated MOC in deriving simulation behaviours that were not known pos-568
sible a priori : varying degrees of persisting autoimmunity in ARTIMMUS. MOC can be569
applied to both parameters and initial conditions, at the same time, as demonstrated in570
these calibration exercises. We do not consider simulation parameter values and initial571
conditions as independent; a poor selection of initial condition values coupled with appro-572
priate parameter values can still fail to deliver the desired simulation dynamic. MOC’s573
successful delivery of these previously unknown simulation dynamics presents an inter-574
esting use case for MOC. It could be used to identify which parameters, and hence com-575
ponents and pathways, need be manipulated to resolve a simulated disease state, therein576
highlighting candidate therapeutic targets. Furthermore, for disease simulations that in-577
corporate potential interventions, MOC can be used to determine optimal intervention578
strategies that exploit synergies between several treatment options.579
We surmise that MOC can support model selection and development. Accurately580
simulating a biological system requires both an appropriate model of the biology, and ap-581
propriate parameter values for that model. There typically exist several options for how582
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to represent a biological concept in simulation, the most suitable of which is often unclear.583
Models must strike a balance between including sufficient complexity to accurately reflect584
the biology’s dynamics, whilst remaining sufficiently simplistic to offer insight. The un-585
successful calibration of a given model of the biology can lead to two conclusions; first,586
that the calibration process was simply unsuccessful in finding a solution that does exist,587
a risk we argue is greatly lessened through MOC; or second, that the model is incapable588
of replicating the biological dynamics in question. In this latter case, MOC can inform589
simulation design, where a succession of putative models can be evaluated until calibra-590
tion is successful. The possibility of directly applying MOC to the space of biological591
abstractions, rather than parameter values, is intriguing, though extremely challenging592
technically. Here, MOC would search for which cells were represented, and how. This593
would encompass their interactions with one another, opting to ignore some found to594
be irrelevant to the biological phenomenon of interest, or vice versa. The level of detail595
through which molecular secretions and expressions where represented could also be de-596
termined; is variable expression level necessary, or does simply ‘present’ vs ‘not’ suffice?597
The challenge herein lies in building an agent-based simulation infrastructure capable598
of capturing all these possibilities, and allowing the automated optimisation process to599
manipulate them. The aforementioned point still applies, for each possible model, the600
space of parameter values must also be investigated, as an accurate reflection of biology601
requires both an appropriate model and corresponding parameter values. Hence, MOC602
would be applied in a nested fashion, firstly over the space of biological representations,603
and therein over the space of parameter values for each model.604
Although our present investigation has employed an agent-based simulation, MOC605
is applicable to other simulation paradigms also, such as ordinary differential equations606
(ODE). Application to non-stochastic simulations, such as ODEs, requires significantly607
less computational power, as there is no need to obtain simulation replicates in assessing608
a candidate solution’s fitness. We note that, from our experience in building them, not609
all biological simulations are as computationally costly to execute and calibrate as AR-610
TIMMUS. Each MOC calibration exercise has taken up to a week of time on a dedicated611
computational facility. In this regard, terminating the MOC process when a threshold612
level of overfitting is detected is pertinent (see Figure 8). Overfitting was detected in613
all three of our ARTIMMUS parameter recalibration exercises, and selecting a threshold614
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of 0.5, wherein half of the MOC solutions at a given point no longer represent optimal615
performance tradeoffs in an independent test, could as much as halve the computational616
effort required.617
The ability to detect overfitting in a multi-objective context is a novel contribution618
of this work. Though a common strategy for stopping a single-objective optimisation619
process, it was previously unclear how to deploy this strategy in a multi-objective context620
[31]. There is another condition under which we feel it pertinent to terminate the MOC621
process. The goal of MOC is to find parameter values yielding simulation dynamics that622
closely resemble some target. As this alignment increases, and differences in solutions’623
simulation performances reduce, it is possible that seemingly better alignments in fact624
represent sampling artefacts arising from the stochastic simulation, rather than genuinely625
superior parameter values. We note that detecting this in a statistically robust manner626
is challenging, and as such we highlight it as potential further work.627
This work fits within the context of a wider framework for supporting complex system628
simulation, the CoSMoS framework [32]. CoSMoS advocates explicitly recording, typically629
through graphical modelling [33], how real world concepts are translated into computer630
code, and the implicit assumptions therein. In this context, MOC can help in relating631
simulation results to biological data. The case where a distribution of results emerges632
from a given biological experiment, even to the point where replicates or individuals633
within an experiment exhibit completely different outcomes, can be handled in MOC634
by defining bi-modal (or multi-modal) target distributions. A scenario wherein MOC635
unexpectedly delivers several distinct and unconnected simulation phenotypes, rather636
than a continuum of points on the Pareto front, is interesting. This can either suggest637
the existence of additional phenotypes to look for in the biology, or if this can be ruled638
out, suggests instead that the model being calibrated fails to accurately capture the639
biology. This later case is an example of how MOC could drive simulation design and640
development, as covered above. Related work on supporting the link of simulation to641
biology proposes the construction of an argument wherein a claim such as ‘this simulation642
is an adequate representation of the biology’ is supported by explicitly cited evidence [34].643
In this context, application of MOC can raise confidence that appropriate parameter and644
initial condition values have been identified. The range of possible values can be contrasted645
against biological literature and data, excluding those deemed implausible. Subsequent646
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simulation experiments can be performed in replicate with those that remain, therein647
highlighting the full range of results that are plausible in absence of better reason to rule648
out particular parameter values. We argue that drawing conclusions from this nature of649
simulation experimentation, and making explicit the full range of parameter values that650
satisfy the calibration problem, leads to more robust conclusions.651
In summary, our novel application of multi-objective optimisation in MOC presents652
the mutli-objective optimisation community with a new field of application, and one we653
feel has considerable scope for growth. Importantly, it provides fundamental support for654
a critical aspect of simulation-based biological experimentation: identifying parameter655
values and initial conditions that align simulations with a complex target behaviour.656
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Figure and table captions758
Figure 1. The ARTIMMUS simulation, used as a testcase for evaluating MOC.759
A, the the major cell types represented in ARTIMMUS, and their key influences on one760
another. Red and green arrows respectively indicate activities that perpetuate autoimmu-761
nity or mediate recovery. Figure adapted from [11]. B, the baseline dynamic of ARTIM-762
MUS, depicting four T cell population sizes over time. The simulation behaviour depicted763
here forms a calibration target for MOC in Section 4. Lines correspond to like-coloured764
cells in Figure A; these colours are maintained throughout the manuscript. Error bars765
capture 90% of the data derived from 500 simulation executions, timeseries lines indicate766
median population sizes at each time point.767
768
769
Figure 2. Overview of the Multi-Objective Calibration (MOC) concept. A,770
The desired (target) simulation dynamics are defined as distributions (only 2 shown): the771
desired distributions of peak cell number and the times at which these occur. Distribu-772
tions are depicted as histograms, or the corresponding cumulative distribution functions773
describing the proportion of samples in the distribution (y axis) that hold a given value774
or less (x axis). B, the capacity for putative simulation parameter (only 2 shown) values,775
termed candidate solutions, to reproduce target dynamics is evaluated. The Kolmogorov-776
Smirnov (KS) statistic quantifies the difference between target and a given candidate777
solution’s simulation performance (left); this metric is termed an objective. By sampling778
and evaluating regions of parameter space we identify those that provide good alignment779
with a given objective, illustrated through greyscale heatmaps (right). No single region780
of parameter space maximizes performance against all objectives (only 2 shown), there781
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exist inherent tradeoffs. A heuristic (guided) search strategy, NSGA-II, is employed to782
strategically sample parameter space. C, solutions representing optimal tradeoffs in per-783
formance against each objective are identified, collectively termed the Pareto front (left).784
These solutions are Pareto-equivalent (pink): no solution has been found that represents785
an improvement in one objective without a worsening in another. Sub-optimal candidate786
solutions are discarded (blue). Pareto-equivalent solutions may reside in disparate regions787
of parameter space(right).788
789
790
Figure 3. Multi-objective calibration (MOC) successfully re-calibrates AR-791
TIMMUS parameters against 5 objectives. The best solution’s, that with lowest792
Λ score, target simulation dynamics are shown. The solution dataset comprises 200 sim-793
ulation replicates, the target comprises 500. A, T cell population sizes over time, for794
both target (dotted line) and solution (solid line). The median values from each dataset795
at the given point in the time series are plotted. B-F, cumulative distribution functions796
showing alignment of solution and target distributions of values for each objective, with797
titles giving KS values. These graphs show the distribution of calibration target values798
obtained in each dataset: the y-axis indicates the proportion of items in the distribution799
holding a value less than or equal to the corresponding x-axis value. Objectives are: B,800
peak CD4Th1 population size cell; C, time at which this peak occurs; D, CD4Th2 pop-801
ulation size at 30 days; E, peak CD4Treg population size; F, peak CD8Treg population802
size. These data represent the first of three independent recalibration experiments.803
804
805
Figure 4. Automated re-calibration of ARTIMMUS parameters delivers so-806
lutions approximating the original manually-calibrated parameter values. Box807
plots are shown for each of three independent calibration exercises. The horizontal green808
line represents the manually-calibrated parameter values. Calibration was performed over809
5 objectives: the peak population sizes of Th1, CD4Treg, CD8Treg cells, the time at which810
the Th1 population peaks, and the number of Th2 cells at 30 days. Parameters subject811
to calibration are listed in Table 1, see Figure S1 for an explanation of their operation in812
ARTIMMUS. Values shown above each plot are the Kolmogorov-Smirnov scores between813
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distributions, shown to one significant figure; the associated p-values are: *, p<0.01 and814
**, p<0.001. Outliers in boxplots are defined as lying beyond the first or third quartiles815
by 1.5 times the interquartile range.816
817
818
Figure 5. The range of objective values that constitute the Pareto front de-819
rived through MOC re-calibration of ARTIMMUS. Box plots are shown for each of820
three independent calibration exercises. These objective values correspond to the Pareto821
front and associated ARTIMMUS parameter values of Figure 4. Calibration was per-822
formed against five objectives: A, the peak population size of Th1 cells; B, the time at823
which this occurred; C, the number of Th2 cells at 30 days; D, the peak population size824
of CD4Treg cells; E, the peak population size of CD8Treg cells. Statistical and boxplot825
formatting are as in Figure 4.826
827
828
Figure 6. Do different regions of MOC’s Pareto front of solutions give rise829
to different results in subsequent experimentation? Top, an overview of the ex-830
perimental procedure. 1, Pareto front members representing objective value extremes831
are identified (only two objectives shown in example). 2, The simulation parameters832
represented by such members are adopted in performing a control and splenectomy ex-833
periment, with 200 replicate simulations in each group. 3, Key performance indicators are834
extracted from the resultant distributions of simulation dynamics, indicated here is the835
peak CD4Treg population size within each individual simulation. 4, Performance indica-836
tors are statistically contrasted for splenectomy and control experiments. These statistics837
are examined across different Pareto front members, thereby gauging the extent to which838
experimental results critically depend on which Pareto-equivalent parameter values are839
adopted in simulation. Tables, columns represent extreme Pareto front solutions, defined840
as having either the highest or lowest KS value for each of the five objectives used in cal-841
ibration (see Section 4). The objective KS value scores are shown in parentheses. Only842
the first occurrence of each solution is shown, with subsequent entries indicated by ‘-’.843
Rows indicate the difference between control and splenectomy simulations based on each844
solution according to key indicators of simulation behaviour, as measured by the Vargha-845
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Delaney A test [25]. The original A test scores for the manually-calibrated simulation846
are shown (‘orig’), as is the biggest difference in A test score observed between manually-847
and automatically-calibrated simulations (‘diff’). Values highlighted in red represent four848
differences in candidate and original A test scores that are notably larger than differences849
observed elsewhere. ‘D.c.’ indicates ‘direction change’, where there exists at least one850
candidate with for which the A test score lay on the other side of 0.5 from the original,851
indicating that the distribution of values under splenectomy increased in the original ex-852
periment but decreased for the candidate (or vice versa).853
854
855
Figure 7. Employing MOC to discover parameter and initial condition val-856
ues delivering simulation dynamics not known to exist a priori : persisting857
autoimmune states of varying severity. Three severities are explored, represented858
as columns. They are, a mean of 50, 200 or 500 Th1 cells at 60 days (with standard859
deviations of 10, 100 and 200 respectively). A second objective is employed in all cases,860
1000 Th1 cells at 15 days, which drives the establishment of autoimmunity. Each severity861
is calibrated in three independent experiments, and shown here are the solutions exhibit-862
ing lowest Λ values from a representative calibration of each experiment. The first row863
of graphs depicts the median T cell time-series. The second row shows the candidate’s864
performance against an objective of 1000 Th1 at 60 days (standard deviation = 200). The865
last row depicts the second objective, the (respective) number of T cells at 60 days.866
867
868
Figure 8. Terminating MOC when overfitting occurs. Overfitting describes the869
case when solutions generated by an optimisation process, e.g. MOC, better resemble870
the target data than the underlying distribution from which it was drawn. A, in many871
contexts, such as animal experiments, only limited samples of a phenomenon can be ob-872
tained. The samples will broadly, but not exactly, reflect the underlying distribution. B,873
an overfitted candidate solution more closely resembles the target data than the underly-874
ing distribution from which the target data was drawn. Detecting this is difficult because875
the true underlying distribution cannot be absolutely known. C, a common strategy in876
single-objective optimisation problems is to divide the available data into two, a training877
29
dataset and a validation dataset. The training dataset is used as the target in obtaining878
successively better quality solutions. The validation dataset is used as an independent879
check. Overfitting is detected when solutions more closely resemble the training dataset880
than validation dataset. This is illustrated in D, where early solutions generally offer881
improved performance against both datasets. It is only in later stages that solutions so882
closely reflect the target dataset that they diverge from the validation dataset. This is883
when the process should be stopped. E. Overfitting can be detected in multi-objective884
optimisation, such as MOC, by maintaining Pareto fronts of optimal solutions against885
both training and validation data independently. The degree of overfitting is reflected886
in the proportion of training data Pareto front solutions that are not members of the887
validation data Pareto front.888
889
890
Figure 9. Empirical results for detecting overfitting in MOC, and when to891
terminate the process accordingly. We generated a validation dataset using AR-892
TIMMUS’s previous manually-calibrated parameter values, and retrospectively analysed893
how overfitted MOC solutions would have been on the three MOC calibration exercises894
reported in Section 4. A, The overfittedness, defined as the proportion of MOC Pareto895
front solutions that are not also members of a similar Pareto front maintained for the896
validation data, at each MOC generation. B, the generation at which MOC would have897
been terminated for a given overfittedness threshold value.898
899
900
Table 1. The ARTIMMUS parameters (top) and initial conditions (bottom) subject to901
calibration, their baseline (manually-calibrated) values, and the lower and upper bounds902
of values they may be assigned during MOC.903
904
905
Table 2. The best solution, being that with the lowest Λ value, arising from each of906
three independent calibration exercises. Shown are each of the five objective KS values.907
We independently investigated the calibration of both ARTIMMUS parameters (top) and908
initial conditions (bottom). High quality calibrations, as indicated by low KS values, were909
30
obtained in all cases.910
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Parameters calibrated
Parameter Baseline value Lower bound Upper bound
APC immatureDuration 48 0 96
APC matureDuration 110 0 220
APC phagocytosisToPeptide 0.02 0 0.04
CNSM MBPExpressionProbability 0.2 0 0.4
DCT1 cytokineSecretionRate 10 0 20
DC T2CytokineRatio 0.17 0 0.34
Th1 diff00 0.05 0 0.1
Th1 diff80 0.85 0 1.0
Initial conditions calibrated
Initial condition Baseline value Lower bound Upper bound
numTh 40 0 80
numCD4Treg 30 0 60
numCD8Treg 30 0 60
numCNS 500 0 1000
numCNSMacrophage 75 0 150
numDC 10 0 20
numDCCNS 40 0 80
numDCSpleen 100 0 200
Table 1:
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Calibration on parameters
Calibration Objective KS value
exercise Th1Peak Th1Time Th2at30d CD4TregPeak CD8TregPeak
1 0.06 0.10 0.08 0.06 0.07
2 0.08 0.06 0.06 0.05 0.07
3 0.05 0.08 0.14 0.08 0.05
Calibration on initial conditions
Calibration Objective KS value
exercise Th1Peak Th1Time Th2at30d CD4TregPeak CD8TregPeak
1 0.06 0.08 0.04 0.03 0.06
2 0.04 0.08 0.10 0.11 0.12
3 0.06 0.06 0.06 0.07 0.05
Table 2:
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